State Street SPDR S&P Biotech ETF XBI
152.21 USD +3.81 (+2.57%)
At closeNov 9, 2026, 6:19 AM EST
153.06 +0.85 +0.56%
Pre-market · Nov 9, 6:19 AM ET
147.56 Day range 152.92
109.28 52-week range 169.89
- YTD
- +24.83%
- 1 year
- +39.69%
- Market cap
- 7.96B
- YTD return
- +24.83%
- 1-year return
- +39.69%
- Volume
- 10.52M
- Avg volume
- 9.08M
- Open
- 148.82
- Previous close
- 148.40
- Day's range
- 147.56 – 152.92
- 52-week range
- 109.28 – 169.89
5m -4.18 (-2.67%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 155.54
- 200-day average
- 142.20
Next earnings
Consensus EPS estimate 0.00.
About State Street SPDR S&P Biotech ETF
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
News
Your note
Sign in to keep a note on XBI — it syncs with the Stock Master app.